CARsgen's Allogeneic CD38 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial
Avis Budget Group(CAR) Prnewswire·2025-01-20 21:50Avis Budget Group(CAR) Prnewswire·2025-01-20 21:50
R1Avis Budget Group(CAR) Prnewswire·2025-01-20 21:50